Straits Times Index
3,380.83 +17.15 (+0.51%) Nikkei
27,509.46 +107.41 (+0.39%) Hang Seng
21,660.47 -297.89 (-1.36%) FTSE 100
7,818.41 -1.75 (-0.02%) BTC-USD
23,403.89 -437.68 (-1.84%) CMC Crypto 200
534.00 -11.31 (-2.07%)
Albemarle Corporation (ALB)
After hours:
| Previous close | 285.90 |
| Open | 288.70 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's range | 285.50 - 291.09 |
| 52-week range | 169.93 - 334.55 |
| Volume | |
| Avg. volume | 1,479,208 |
| Market cap | 33.992B |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | 22.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.58 (0.55%) |
| Ex-dividend date | 15 Dec 2022 |
| 1y target est | N/A |
- Motley Fool
Lithium Stock Albemarle Provides a Massive Boost to Long-Term Growth Targets -- Time to Buy?
Electric vehicle (EV) stocks have been all the rage for a few years now, and for good reason. If all those new EVs are indeed manufactured in the next eight years, the global supply of lithium will need to balloon. Albemarle just released its growth targets for the next five years, and if management's goals are attainable, this could be one cheap stock right now.
- Motley Fool
The Ultimate Growth Stocks to Buy With $300 Right Now
Long-term investors looking to overcome the effects of inflation can find some satisfaction from quality growth stocks, especially from companies generating triple-digit growth in revenue and share-price appreciation. Shares of Inspire Medical Systems (NYSE: INSP), Axsome Therapeutics (NASDAQ: AXSM), and Abermarle (NYSE: ALB) can all be purchased for under $300. All three companies have had triple-digit percentage revenue and share-price growth over the past five years.
- Motley Fool
Why Shares of Albemarle Are Powering Higher This Week
Charging up investors' beliefs that the company will thrive in the coming years, Albemarle (NYSE: ALB) provided an auspicious business update on Wednesday. As of 10:49 a.m. ET today, shares of Albemarle had risen 12.1% since last Friday, according to data provided by S&P Global Market Intelligence. Management provided multiple figures to suggest Albemarle is poised for significant growth, using preliminary numbers for 2022.
